VitaLonga

Clinical trial · Exercise · 13 Nov 2026

In 30 women after breast cancer, an app-based exercise pilot did not beat usual activity

Source: DIGITAL HEALTH

What the research found

A pilot randomized trial was published online on 13 November 2026. Virtual Mate Me enrolled pre-menopausal women who had finished primary treatment for breast cancer at least six months earlier, with no recurrence. 30 were randomized and 22 finished. Mean age was 32.59 years (standard deviation 5.89). The program was 24 sessions over 8 weeks of app-guided exercise, versus usual activity. Retention was 73.33 percent. Adherence was 83.33 percent. The system usability score was 76.75. Gaps versus usual activity were not significant for menopausal symptoms, physical function, or quality of life. Inside the exercise group, upper-limb disability (p=0.013) and lower-limb strength (p=0.037) changed over time, and menopausal symptoms moved (p=0.058). Those within-group shifts were not different from usual activity. A small pilot, not a definitive test. DOI 10.1177/20552076261501916. Not medical advice.

Evidence level: Clinical trial. This is among the stronger kinds of evidence, but one study rarely settles a question.

Read the original at DIGITAL HEALTH

More exercise news